Novel therapeutic strategies targeting the epidermal growth factor receptor (EGFR) family and its downstream effectors in breast cancer.

Atalay G., Cardoso F., Awada A., Piccart M.

Annals of oncology : official journal of the European Society for Medical Oncology, cilt.14, ss.1346-63, 2003 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 14
  • Basım Tarihi: 2003
  • Doi Numarası: 10.1093/annonc/mdg365
  • Dergi Adı: Annals of oncology : official journal of the European Society for Medical Oncology
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.1346-63
  • Anahtar Kelimeler: Akt, breast cancer, EGFR (ErbB) family, HER-2, MAPK, TYROSINE KINASE INHIBITOR, ESTROGEN-RECEPTOR, ZD1839 IRESSA, MONOCLONAL-ANTIBODY, PHASE-II, PROGNOSTIC VALUE, CROSS-TALK, HER2 OVEREXPRESSION, SIGNAL-TRANSDUCTION, BISPECIFIC ANTIBODY
  • Acıbadem Mehmet Ali Aydınlar Üniversitesi Adresli: Hayır